Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Fiebach

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Medicine|July 1, 1990
Outcomes in patients with myocardial infarction who are initially admitted to stepdown units: data from the Multicenter Chest Pain StudyN H Fiebach, E F Cook, T H Lee, et al.
American Journal of Epidemiology|October 1, 1989
A prospective study of high blood pressure and cardiovascular disease in womenN H Fiebach, P R Hebert, M J Stampfer, et al.
Lancet (London, England)|April 7, 1990
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextR Collins, R Peto, S MacMahon, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Medicine|July 1, 1990
Outcomes in patients with myocardial infarction who are initially admitted to stepdown units: data from the Multicenter Chest Pain StudyN H Fiebach, E F Cook, T H Lee, et al.
American Journal of Epidemiology|October 1, 1989
A prospective study of high blood pressure and cardiovascular disease in womenN H Fiebach, P R Hebert, M J Stampfer, et al.
Lancet (London, England)|April 7, 1990
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextR Collins, R Peto, S MacMahon, et al.
Pageof 2